Skip to content

Amgen AMGN Debt Repayments

Debt Repayments at other companies

Eli Lilly logo
Eli LillyLLY
$750M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$7.5M
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$13.66M

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$195.44B+34.6%
Enterprise value$252.2B+25.7%
P/E25.1×+3.1×
P/S5.3×+1.1×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's debt repayments?
Amgen (AMGN) reported debt repayments of $833M in Q1 2026.
How has Amgen's debt repayments changed year-over-year?
Amgen's debt repayments decreased by 66.7% year-over-year, from $2.5B to $833M.
What is the long-term trend for Amgen's debt repayments?
Over 3 years (2021 to 2025), Amgen's debt repayments has grown at a 6.4% compound annual growth rate (CAGR), from $4.15B to $5B.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.